Westchester Capital Management (New York)’s Aerie Pharmaceuticals AERI Stock Holding History

Westchester Capital Management (New York)’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-15,000	Closed	-$227K	–	589
2022 Q3	$227K	Buy	+15,000	New	+$174K	0.01%	398

Westchester Capital Management (New York)'s AERI Position: Q4 2022 in Review

Westchester Capital Management (New York) sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 15,000 shares — an estimated $227K sold.

Westchester Capital Management (New York) first reported a position in AERI in Q3 2022 and held it in 1 quarter. The position peaked at $227K in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Westchester Capital Management (New York) reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Westchester Capital Management (New York) sold 15,000 Aerie Pharmaceuticals shares in Q4 2022, an estimated $227K.
Westchester Capital Management (New York) first reported a position in Aerie Pharmaceuticals in Q3 2022 and held it in 1 quarter.
Westchester Capital Management (New York)'s Aerie Pharmaceuticals position peaked at $227K in Q3 2022.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Westchester Capital Management (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.